Plans to expand African vaccine production face steep hurdles.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38635705.
- Also identified by DOI 10.1126/science.adp8885.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Moderna's pause on Kenya project highlights difficulties in creating a competitive vaccine sector on the continent.
Medical subject headings
- COVID-19 Vaccines